HC
PMN icon

Hara Capital’s ProMIS Neurosciences PMN Stock Holding History

Hara Capital’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,177
Closed -$27.9K – 323
2024
Q4 		$27.9K Buy
+1,177
New +$29.3K 0.01% 244
2024
Q3 		– Sell
-1,177
Closed -$44.1K – 303
2024
Q2 		$44.1K Hold
1,177
– – 0.03% 134
2024
Q1 		$56.2K Buy
+1,177
New +$58.3K 0.03% 133

Other funds holding PMN

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $9.19B AUM 25.65% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Hara Capital's PMN Position: Q1 2025 in Review

Hara Capital sold out of ProMIS Neurosciences (PMN) in Q1 2025, closing a stake of 1,177 shares — an estimated $27.9K sold.

Hara Capital first reported a position in PMN in Q1 2024 and held it in 3 quarters. The position peaked at $56.2K in Q1 2024. 15 funds tracked by Wall St. Rank hold PMN as of Q1 2025.

  • Hara Capital reported no remaining ProMIS Neurosciences position as of Q1 2025 after selling out during the quarter.
  • Hara Capital sold 1,177 ProMIS Neurosciences shares in Q1 2025, an estimated $27.9K.
  • Hara Capital first reported a position in ProMIS Neurosciences in Q1 2024 and held it in 3 quarters.
  • Hara Capital's ProMIS Neurosciences position peaked at $56.2K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2025.

Based on Hara Capital's 13F filing for Q1 2025, filed 30 Apr 2025.